Profile data is unavailable for this security.
About the company
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.
- Revenue in USD (TTM)213.52bn
- Net income in USD-365.00m
- Incorporated1994
- Employees78.00k
- LocationMcKesson Corp1 Post StSAN FRANCISCO 94104-5203United StatesUSA
- Phone+1 (415) 983-8300
- Fax+1 (302) 636-5454
- Websitehttp://www.mckesson.com
Mergers & acquisitions
| Acquired company | MCK:NYQ since announced | Transaction value |
|---|---|---|
| Medical Specialties Distributors LLC | -8.95% | 800.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan NV | 11.59bn | 652.90m | 16.42bn | 35.00k | 25.72 | 1.36 | 6.29 | 1.42 | 1.24 | 1.04 | 22.24 | 23.40 | 0.3347 | 2.70 | 3.99 | 331,260.00 | 1.88 | 3.31 | 2.21 | 4.11 | 40.61 | 44.71 | 5.63 | 7.89 | 0.7683 | 3.86 | 0.5453 | 0.00 | 7.50 | 11.87 | 71.79 | 5.17 | 24.03 | -- |
| Cardinal Health Inc | 141.94bn | -40.00m | 16.53bn | 50.20k | -- | 2.74 | 17.01 | 0.1165 | -0.0861 | -0.0805 | 461.20 | 20.28 | 3.41 | 10.74 | 18.20 | 2,827,391.00 | -0.0912 | 2.73 | -0.2089 | 6.29 | 4.96 | 5.35 | -0.0268 | 0.7671 | 0.5060 | 5.93 | 0.5996 | 58.28 | 5.26 | 6.24 | -149.61 | -- | 14.51 | 12.53 |
| BioMarin Pharmaceutical Inc. | 1.50bn | -87.25m | 16.74bn | 2.58k | -- | 5.74 | 1,348.38 | 11.18 | -0.495 | -0.7098 | 8.48 | 16.39 | 0.3226 | 0.6548 | 4.70 | 579,737.70 | -1.88 | -7.62 | -2.18 | -8.62 | 78.87 | 82.21 | -5.83 | -25.70 | 2.26 | -11.73 | 0.2917 | -- | 17.62 | 21.28 | 88.14 | -- | 34.91 | -- |
| Incyte Corporation | 1.88bn | 109.49m | 17.91bn | 1.37k | 166.94 | 9.32 | 108.89 | 9.52 | 0.5041 | 0.5041 | 8.77 | 9.03 | 0.7606 | 10.80 | 6.56 | 1,376,652.00 | 4.43 | -1.91 | 5.28 | -2.33 | 96.14 | 96.44 | 5.82 | -2.44 | 4.29 | 3.41 | 0.009 | -- | 22.50 | 39.60 | 134.97 | -- | 76.69 | -- |
| AmerisourceBergen Corp. | 172.87bn | 1.13bn | 18.29bn | 21.00k | 16.77 | 6.00 | 11.28 | 0.1058 | 5.17 | 5.46 | 790.71 | 14.45 | 4.57 | 14.12 | 14.98 | 8,231,703.00 | 2.87 | 2.00 | 11.16 | 8.55 | 2.75 | 2.73 | 0.627 | 0.4063 | 0.5341 | 7.63 | 0.5962 | 47.29 | 9.66 | 13.81 | 186.93 | 16.21 | 10.69 | 12.59 |
| McKesson Corporation | 213.52bn | -365.00m | 26.00bn | 78.00k | -- | 2.83 | 31.22 | 0.1218 | -1.60 | -1.36 | 1,066.26 | 47.84 | 3.41 | 11.86 | 10.96 | 2,737,410.00 | -0.2156 | 3.80 | -0.5761 | 10.22 | 5.45 | 5.87 | -0.0632 | 1.13 | 0.571 | 9.91 | 0.4755 | 12.24 | 4.95 | 11.29 | -115.50 | -- | 8.54 | 9.16 |
| Iqvia Holdings Inc | 10.41bn | 232.00m | 28.38bn | 55.00k | 127.37 | 4.17 | 20.52 | 2.73 | 1.11 | 1.24 | 50.01 | 33.99 | 0.4586 | -- | 4.64 | -- | 1.07 | 3.78 | 1.27 | 4.67 | 35.21 | 32.15 | 2.32 | 6.34 | -- | 1.88 | 0.6128 | -- | 7.32 | 15.35 | -79.72 | 2.71 | 39.04 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2018 | 16.27m | 8.33% |
| BlackRock Fund Advisorsas of 31 Dec 2018 | 9.35m | 4.79% |
| Wellington Management Co. LLPas of 31 Dec 2018 | 8.94m | 4.57% |
| SSgA Funds Management, Inc.as of 31 Dec 2018 | 8.81m | 4.51% |
| Massachusetts Financial Services Co.as of 31 Dec 2018 | 5.52m | 2.83% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2018 | 5.35m | 2.74% |
| Glenview Capital Management LLCas of 31 Dec 2018 | 4.52m | 2.31% |
| Vulcan Value Partners LLCas of 31 Dec 2018 | 4.49m | 2.30% |
| Invesco Advisers, Inc.as of 31 Dec 2018 | 4.24m | 2.17% |
| Fidelity Management & Research Co.as of 31 Dec 2018 | 3.42m | 1.75% |
